Skip to main content

Advertisement

ADVERTISEMENT

News

News
03/04/2023
Twenty cardiovascular professionals have been named 2023 Distinguished Award winners by the American College of Cardiology, recognizing their outstanding contributions to cardiovascular medicine.
Twenty cardiovascular professionals have been named 2023 Distinguished Award winners by the American College of Cardiology, recognizing their outstanding contributions to cardiovascular medicine.
Twenty cardiovascular...
03/04/2023
Cath Lab Digest
News
03/04/2023
The TRILUMINATE™ Pivotal study evaluates the superiority of TriClip compared to medical therapy in treating patients with severe, symptomatic tricuspid regurgitation (TR) who are at intermediate or greater risk for open-heart surgery.
The TRILUMINATE™ Pivotal study evaluates the superiority of TriClip compared to medical therapy in treating patients with severe, symptomatic tricuspid regurgitation (TR) who are at intermediate or greater risk for open-heart surgery.
The TRILUMINATE™ Pivotal study...
03/04/2023
Cath Lab Digest
News
03/04/2023
Primary outcomes from the TRILUMINATE™ Pivotal clinical trial show the TriClip™ demonstrated superiority to medical therapy in improving quality of life and reducing tricuspid regurgitation.
Primary outcomes from the TRILUMINATE™ Pivotal clinical trial show the TriClip™ demonstrated superiority to medical therapy in improving quality of life and reducing tricuspid regurgitation.
Primary outcomes from the...
03/04/2023
Cath Lab Digest

Advertisement

News
03/04/2023
Viz.ai will use its Viz™ RECRUIT platform to optimize patient enrollment for the NIH-funded(1) Pulmonary Embolism—Thrombus Removal with Catheter-Directed Thrombolysis (PE-TRACT) clinical trial.
Viz.ai will use its Viz™ RECRUIT platform to optimize patient enrollment for the NIH-funded(1) Pulmonary Embolism—Thrombus Removal with Catheter-Directed Thrombolysis (PE-TRACT) clinical trial.
Viz.ai will use its Viz™ RECRUIT...
03/04/2023
Cath Lab Digest
News
03/03/2023
The HyperVue system is the first to combine two critically important imaging technologies, DeepOCT and NIRS, while optimizing for image quality and procedural efficiency in the cath lab.
The HyperVue system is the first to combine two critically important imaging technologies, DeepOCT and NIRS, while optimizing for image quality and procedural efficiency in the cath lab.
The HyperVue system is the first...
03/03/2023
Cath Lab Digest
News
03/02/2023
Analyzing the most extensive datasets in the United States, researchers from the Icahn School of Medicine at Mount Sinai have revealed that vaccination against COVID-19 is associated with fewer heart attacks, strokes, and other cardiovascular...
Analyzing the most extensive datasets in the United States, researchers from the Icahn School of Medicine at Mount Sinai have revealed that vaccination against COVID-19 is associated with fewer heart attacks, strokes, and other cardiovascular...
Analyzing the most extensive...
03/02/2023
Cath Lab Digest

Advertisement

News
03/02/2023
These new cutpoints for the young population are higher than the pediatric cutpoint and lower than the adult cutpoint, except among 24-year-old males.
These new cutpoints for the young population are higher than the pediatric cutpoint and lower than the adult cutpoint, except among 24-year-old males.
These new cutpoints for the...
03/02/2023
Cath Lab Digest
News
03/02/2023
Austin, TX — Austin, TX-based Arise Vascular announced the opening of its newest outpatient cardiovascular catheterization lab in Gautier, Mississippi, bringing a new level of convenience, cost savings, and state-of-the-art care to the...
Austin, TX — Austin, TX-based Arise Vascular announced the opening of its newest outpatient cardiovascular catheterization lab in Gautier, Mississippi, bringing a new level of convenience, cost savings, and state-of-the-art care to the...
Austin, TX — Austin, TX-based...
03/02/2023
Cath Lab Digest
News
03/01/2023
The study found that in patients at high risk of developing cardiovascular disease, over 20 percent refused to take statin medications.
The study found that in patients at high risk of developing cardiovascular disease, over 20 percent refused to take statin medications.
The study found that in patients...
03/01/2023
Cath Lab Digest

Advertisement

News
03/01/2023
The research team showed that a modified version of hemoglobin, termed S-nitrosohemoglobin, senses areas with insufficient oxygen, and then restores blood flow for oxygenation.
The research team showed that a modified version of hemoglobin, termed S-nitrosohemoglobin, senses areas with insufficient oxygen, and then restores blood flow for oxygenation.
The research team showed that a...
03/01/2023
Cath Lab Digest

Advertisement